Enhancing Analgesia in Chronic Pain Through Exercise

Enhancing Analgesia in Chronic Pain Through Exercise: Responsivity of Sensory-Motor Networks and Factors That Moderate the Analgesic Response

Background: Current pain management strategies for pediatric patients are not integrating the analgesic potential of movement-based therapies. To date, experiencing a painful stimulus has been known to disrupt motor activity in an attempt to minimize injury. However, physical activity, even when it increases ongoing pain initially, has been shown to significantly reduce pain symptoms eventually through neuromodulation. In both acute and chronic pain cohorts, exercise protocols and neuromodulation paradigms have produced exercise-related analgesia. Problem: It is not currently understood which brain regions are implicated in exercise-based analgesia and what brain regions moderate this response.

Approach: The investigators intend to provide a physical activity intervention designed to promote exercise-induced analgesia. This intervention will be performed in a group of pediatric subjects with Chronic Widespread Pain Disorder. An exercise (n=10), no exercise (n=10) and healthy control (n=10) group will be recruited. Aims: This study has three aims: (1) To understand how thermal pain sensitivity, pain symptoms and motor performance are impacted in patients with chronic pain after an exercise-based intervention. (2) To evaluate the brain regions involved in a simple motor task as well as how motor activity influences activity in pain regions of the brain. (3) To evaluate the network structure of the brain, with special emphasis on motor and pain regions, in youth with a pain disorder who have undergone an exercise-based intervention. Exercise-based therapy in pediatric subjects with a chronic pain condition is predicted to reduce pain symptom reporting through biasing activity in pain regions during motor performance. Significance: Findings from this investigation will address the clinical side of pain management strategies and provide potential therapeutic targets and feasibility data. The investigators anticipate that findings will show how pain and motor regions of the brain interact at the network level and if this interaction can be modulated through exercise. Findings will also evaluate the brain regions that mediate the analgesic properties of an exercise-based pain therapy and provide future therapeutic targets.

Study Overview

• Status: Recruiting
• Conditions: Pain; Chronic Widespread Pain; Fibromyalgia
• Intervention / Treatment: Behavioral: Physical Activity - Pediatric Pain Rehabilitation Center

Detailed Description

This investigation is aimed at understanding how an exercise program currently performed at the Pediatric Pain Rehabilitation Center (PPRC) at Boston Children's Hospital, designed for individuals with chronic widespread pain is associated with pain relief and how this pain relief relates to changes in the brain. The specific aims/objectives are to explore the following:

Aim 1 - Pain and sensorimotor behavior: To understand how thermal pain sensitivity, pain symptoms and motor performance are impacted in children with chronic pain after an exercise-based intervention. Sensory testing (for Hot & Cold) will be collected using Quantitative Sensory Testing (QST) to establish pain thresholds. To address motor performance, we will perform the Bruininks-Oseretsky Test (BOT) 1 of motor proficiency (examining muscle power, strength, endurance). Pain symptom levels will be evaluated using self-report questionnaires that address fear of pain, pain catastrophizing, and pain symptom load.

Aim 2 - Defining hierarchies during motor performance: To evaluate the brain regions involved in a simple motor task as well as how motor activity influences activity in pain regions. Participants will perform a tapping task within the MRI scanner to evaluate the brain regions that are active during motor control. 2 Functional magnetic resonance images will be processed using dynamic causal modeling (DCM) to evaluate effective connectivity (Figure 2) during task performance. Brain regions evaluated in DCM will be defined by the healthy control cohort.

Aim 3 - Network structure: To evaluate the network structure of the brain, with emphasis on motor and pain regions, in persons with a pain disorder who have undergone an exercise intervention. Graph theory analyses implemented using resting-state functional magnetic resonance imaging will be performed to extract metrics reflecting network efficiency, nodal degree, and nodal centrality. Structural metrics (e.g., cortical thickness and white matter connectivity) will be collected as nuisance variables. Correlation analyses will be performed between network metrics and behavior (fear of pain, pain catastrophizing, motor performance) to evaluate their influence over network reorganization observed from the exercise intervention. Brain regions that define canonical pain and motor networks will be indexed from the healthy control group.

• Study Type: Interventional
• Enrollment (Anticipated): 30
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Scott Holmes, PhD; Phone Number: 6179196648; Email: scott.holmes@childrens.harvard.edu

Study Locations

• United States
  • Massachusetts
    • Boston, Massachusetts, United States, 02115
      • Recruiting
      • Boston Children's Hospital
      • Contact: Scott A Holmes, PhD; Phone Number: 617-919-6648; Email: scott.holmes@childrens.harvard.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 10 years to 24 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Otherwise healthy participants between the ages of 10 and 24
• Actively on the waitlist for, or having completed the exercise program at the PPRC
• Comprehension of instructions
• Parental consent for minors
• Weight less than 250 lbs - limit of MRI table
• Clinical diagnosis of Chronic Widespread Pain

Exclusion Criteria:

• Preventative medications and opioids
• Metallic implants that will pose harm to the subject (e.g., pacemaker) and/or affect the dat (e.g., braces)
• Significant medical disease (systemic or CNS).
• Active suicidality, psychosis, diagnosed eating disorders, and/or other severe clinically diagnosed neuro-psychiatric conditions
• Pregnant
• Claustrophobia

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Healthy Controls; A cohort (n=10) of participants will be recruited who do not have any neurological conditions and are age and sex-matched to participants in Arms 2 and 3.
No Intervention: Chronic Widespread Pain; A cohort (n=10) of participants who have not yet begun the exercise program and are currently on the waitlist for the exercise program at the PPRC
Active Comparator: Chronic Widespread Pain - Exercise; A cohort (n=10) of participants who have completed the exercise program at the PPRC. These individuals will be evaluated the day of their last treatment visit	Behavioral: Physical Activity - Pediatric Pain Rehabilitation Center; While admitted to the Pediatric Pain Rehabilitation Center program, patients receive 1-3 hours of individual and group physical therapy 5 times per week and completed a 30-60 minute home exercise program 9 times per week. The median length of stay for the program is 5 weeks. The amount of aerobic exercise prescribed is individualized to each patient and ranged from 10-20 minutes per session. The duration of aerobic exercise prescribed progressed by 5-10 min weekly until the child reached 20-30 minutes. Patients are instructed to reach a moderate to vigorous intensity of exercise (defined at 5-7/10 rate of perceived exertion). The mode of exercise varied dependent on patient ability and interest. Typical modes of exercise included: walking, running, stationary biking, swimming, sports (i.e., soccer, dance), and online aerobic workouts. Patients were prescribed an individualized 30-60 minute discharge home program using the same structure upon completing the program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in effective connectivity	Difference in effective connectivity between motor and pain regions of the brain between persons who have completed the PPRC intervention and those on the waitlist. Whole-brain effective connectivity will be evaluated and compared between groups that will be age and sex-matched. Effective connectivity will be calculated using dynamic causal modeling and evaluated using a tapping task. Effective connectivity will be calculated from a motor task requiring participants to complete an active (tapping) and rest (no tapping) condition.	8 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Thermal sensitivity	Quantitative sensory testing (QST) will be used to evaluate thermal sensitivity to hot and cold stimulus paradigms. The outcome measure of interest will be participants self-reported pain ratings using a visual analogue scale (VAS) from 0 (minimum - no pain) to 10 (maximum - high pain) at specific levels of thermal sensitivity.	8 months

Collaborators and Investigators

• Sponsor: Boston Children's Hospital
• Investigators: Principal Investigator: Scott Holmes, PhD, Boston Children's Hospital

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2022
• Primary Completion (Anticipated): August 1, 2022
• Study Completion (Anticipated): November 1, 2022

Study Registration Dates

• First Submitted: April 16, 2021
• First Submitted That Met QC Criteria: April 23, 2021
• First Posted (Actual): April 28, 2021

Study Record Updates

• Last Update Posted (Actual): May 11, 2022
• Last Update Submitted That Met QC Criteria: May 6, 2022
• Last Verified: May 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nervous System Diseases; Pain; Neurologic Manifestations; Musculoskeletal Diseases; Rheumatic Diseases; Muscular Diseases; Neuromuscular Diseases; Chronic Pain; Fibromyalgia
• Other Study ID Numbers: IRB-P00034939

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: There are currently no plans to share individual participant data.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No